IMRIS Inc. has announced U.S. Food and Drug Administration clearance of the newest generation VISIUS Surgical Theatre that integrates Siemens’ latest high-field MR scanners.

The new core imaging technology, based on Siemens Aera 1.5T(tesla) and Skyra 3.0T technology, helps IMRIS deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition and improved ease-of-use and workflow during neurosurgical procedures using intraoperative MRI (iMRI).

The addition of these MR systems expands the industry-leading 1.5T and 3.0T MRI choices hospitals have when considering the unique, ceiling-mounted IMRIS solution for intraoperative imaging which brings the MRI to the patient during the procedure.

The first installation of this new generation VISIUS Surgical Theatre will be a four-room hybrid operating room suite at Dartmouth-Hitchcock Medical Center in Lebanon, N.H.